Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
65.01
+1.42 (2.23%)
Jul 30, 2025, 1:54 PM - Market open
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $2.12 billion as of July 30, 2025. Its market cap has increased by 45.07% in one year.
Market Cap
2.12B
Enterprise Value
1.92B
1-Year Change
45.07%
Ranking
Category
Stock Price
$65.01
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $2.12B, an increase of 1,363.45%. That is a compound annual growth rate of 128.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 2.02B | 3.64% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.58B |
| Johnson & Johnson | 405.32B |
| AbbVie | 336.11B |
| Novo Nordisk | 315.59B |
| UnitedHealth Group | 254.96B |
| Novartis AG | 225.74B |
| AstraZeneca | 225.08B |
| Abbott Laboratories | 220.16B |